Related Experiment Video
Updated: Aug 9, 2026
07:30
Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique
Published on: April 1, 2022
Brachial-jugular expanded PTFE grafts for dialysis
Annals of Vascular Surgery
|October 23, 2001
Summary
Brachial-jugular grafts for dialysis offer a viable alternative to complex procedures, demonstrating successful outcomes when performed under local anesthesia in an ambulatory setting. This approach is suitable for patients with subclavian vein stenosis or occlusion.
Area of Science:
- Vascular Surgery
- Nephrology
- Dialysis Access
Background:
- End-stage renal disease necessitates reliable vascular access for hemodialysis.
- Brachial-jugular grafts present a surgical option for patients requiring chronic dialysis.
- Subclavian vein stenosis or occlusion poses a challenge for traditional access methods.
Purpose of the Study:
- To evaluate the long-term outcomes of brachial-jugular grafts in dialysis patients.
- To assess the feasibility of performing these grafts under local anesthesia in an ambulatory setting.
- To compare this technique with alternative dialysis access options.
Main Methods:
- Analysis of 51 patients undergoing brachial-jugular graft placement for dialysis.
- Inclusion of patient age and diabetic nephropathy as factors.
- Evaluation of angio-access complications and their management.
- Utilization of the life-table method for analyzing angio-access duration.
- All procedures conducted under local anesthesia in an ambulatory surgical setting.
Main Results:
- Brachial-jugular grafts can be safely performed under local anesthesia.
- Ambulatory surgical setting is feasible for this procedure.
- The technique demonstrated effectiveness as an alternative access method.
- Successful management of complications was observed.
Conclusions:
- Brachial-jugular grafts are a safe and effective option for dialysis access.
- Local anesthesia and ambulatory surgery are suitable for this procedure.
- This method provides an alternative for patients with subclavian vein issues, avoiding more complex interventions.
Related Concept Videos
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:25Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
01:24Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...